Skip to main content
. 2017 Jan 26;356:i6773. doi: 10.1136/bmj.i6773

Table 3.

Neonatal and maternal outcomes in complete case analysis. Values are numbers (percentages) unless stated otherwise

Outcomes Atosiban (n=410) Fenoterol (n=408) Relative risk (95% CI) P value
Mean (SD) gestational age at delivery (weeks) 38.9 (1.3) 38.9 (1.9) 0.70
Mean (SD) mean time to delivery (days) 22 (9.1) 22 (9.6) - 0.23
Fetal mortality 0 (0.0) 0 (0.0) - -
Neonatal mortality 0 (0.0) 2 (0.1) - 0.15
Admission to neonatal intensive care for >24 hours* 16 (0.4) 17 (0.4) 0.94 (0.48 to 1.8) -
Apgar score <7 at 5 minutes† 6 (1) 13 (3) 0.45 (0.17 to 1.20) -
Mean (SD) birth weight (g)‡ 3356 (460) 3364 (523) - 0.81
Female 204 (50) 204 (50) 1.00 (0.87 to 1.14) -
Mean (SD) blood loss (mL)§ 474 (473.2) 470 (447.3) - 0.92
Women requiring blood transfusions¶ 6 (1) 7 (2) 0.86 (0.29 to 2.5) -
Mean (SD) maternal postpartum hospital stay (days)** 290 (3.1) 287 (3.1) - 0.94
Maternal postpartum complications†† 15 (4) 16 (4) 0.94 (0.74 to 1.9) -

*Missing data: n=399 for atosiban, n=397 for fenoterol.

†Missing data: n=399 for atosiban, n=397 for fenoterol.

‡Missing data: n=394 for atosiban, n=396 for fenoterol.

§Missing data: n=390 for atosiban, n=389 for fenoterol.

¶Missing data: n=400 for atosiban, n=401 for fenoterol.

**Missing data: n=398 for atosiban, n=395 for fenoterol.

††Missing data: n=385 for atosiban, n=386 for fenoterol. Complications: puerperal fever, (suspected) endometritis, mastitis, operation for remove placental tissue, and pulmonary embolism.